JAMP PHARMA CORPORATION — Simvastatin Importer Profile
Pharmaceutical Importer · #17 buyer for Simvastatin · $571.6K import value · 54 shipments · CANADA · DGFT Verified
JAMP PHARMA CORPORATION is the #17 importer of Simvastatin from India with $571.6K in import value and 54 verified shipments. JAMP PHARMA CORPORATION holds a 0.5% market share in Simvastatin imports based in CANADA. The company sources from 2 verified suppliers across 39 formulations shipped to 1 country. Overall, JAMP PHARMA CORPORATION imports 14 pharmaceutical products worth $13.3M across 9 therapeutic categories.
JAMP PHARMA CORPORATION — Simvastatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Simvastatin to JAMP PHARMA CORPORATION?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDREICH LIMITED | $569.4K | 53 | 99.6% |
| 12/8 SARASWATHI AMMAL STREET | $2.2K | 1 | 0.4% |
JAMP PHARMA CORPORATION sources Simvastatin from 2 verified Indian suppliers based on 54 customs records. The primary supplier is MEDREICH LIMITED accounting for 99.6% of imports.
How Does JAMP PHARMA CORPORATION Compare to Nearest Simvastatin Importers?
Buyers ranked immediately above and below #17 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | XXRTHXXAR XXALTXXAREX | UNITED STATES | $600.0K | 12 | $50.0K |
| 16 | SIVEM PHARMACEUTICALS | CANADA | $587.8K | 98 | $6.0K |
| 17 | JAMP PHARMA CORPORATION ★ | CANADA | $569.3K | 51 | $11.2K |
JAMP PHARMA CORPORATION ranks #17 among 421 Simvastatin importers from India. Average shipment value of $11.2K compared to the market average of $60.3K. The closest competitors by value are XXRTHXXAR XXALTXXAREX and SIVEM PHARMACEUTICALS.
Where Does JAMP PHARMA CORPORATION Import Simvastatin To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $571.6K | 54 | 100.0% |
JAMP PHARMA CORPORATION imports Simvastatin to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $571.6K.
What Simvastatin Formulations Does JAMP PHARMA CORPORATION Import?
| Formulation | Value | Shipments |
|---|---|---|
| SIMVASTATIN TABLETS USP 40MG (JAMP SIMV | $86.9K | 4 |
| SIMVASTATIN TABLETS USP 20MG (JAMP SIMV | $77.3K | 4 |
| SIMVASTATIN TABLETS USP 10MG (JAMP SIMV | $35.8K | 3 |
| SIMVASTATIN TABLETS USP 20MG(JAMP SIMVASTATIN 20MG) 100S (13350 PACKS) | $31.8K | 1 |
| SIMVASTATIN TABLETS USP 20MG (JAMP SIMVASTATIN 20MG ) 100S (6180 PACKS) | $29.2K | 2 |
| SIMVASTATIN TABLETS USP 20MG (JAMP SIMVASTATIN 20MG) 100S (12000 PACKS)KGS | $28.5K | 1 |
| SIMVASTATIN TABLETS USP 40MG(JAMP SIMVASTATIN 40MG) 100S (7260 PACKS)29.04KGS | $24.9K | 1 |
| SIMVASTATIN TABLETS USP 10MG (JAMP SIMVASTATIN 10MG ) 100S (6195 PACKS) | $23.4K | 2 |
| SIMVASTATIN TABLETS USP 10MG (JAMP SIMVASTATIN 10MG) 100S (12205 PACKS)KGS | $23.2K | 1 |
| SIMVASTATIN TABLETS USP 40MG (JAMP SIMVASTATIN 40MG) 100S (6330 PACKS) | $21.5K | 1 |
JAMP PHARMA CORPORATION imports 39 distinct Simvastatin formulations from India. The top formulation is SIMVASTATIN TABLETS USP 40MG (JAMP SIMV with 4 shipments worth $86.9K.
Regulatory Requirements: Importing Simvastatin into Canada
What JAMP PHARMA CORPORATION and other importers must comply with to import Simvastatin from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Simvastatin
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Simvastatin from India and How Much Does JAMP PHARMA CORPORATION Import?
India exported $25.4M worth of Simvastatin through 3,854 shipments from 150 suppliers to 84 countries, serving 421 buyers globally. JAMP PHARMA CORPORATION imports $571.6K of this total, accounting for 0.5% of India's Simvastatin exports with 54 shipments from CANADA. This is verified from 54 customs shipment records covering 39 distinct formulations.
What Is the Average Order Value for JAMP PHARMA CORPORATION's Simvastatin Imports?
JAMP PHARMA CORPORATION's average Simvastatin order value is $10.6K per consignment, based on 54 shipments totaling $571.6K. JAMP PHARMA CORPORATION is based in CANADA and ranks #17 among all Simvastatin importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Simvastatin to JAMP PHARMA CORPORATION?
JAMP PHARMA CORPORATION sources Simvastatin from 2 verified Indian suppliers: MEDREICH LIMITED ($569.4K, 99.6%), 12/8 SARASWATHI AMMAL STREET ($2.2K, 0.4%). This is based on 54 customs records.
How Does JAMP PHARMA CORPORATION Compare to Other Simvastatin Importers?
JAMP PHARMA CORPORATION ranks #17 among 421 Simvastatin importers from India with a 0.5% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($8.9M), APL SWIFT SERVICES (MALTA) LTD., ($5.6M), MYLAN HUNGARY KFT, ($1.9M). JAMP PHARMA CORPORATION processed 54 shipments from CANADA.
What Other Cardiovascular Products Does JAMP PHARMA CORPORATION Import?
JAMP PHARMA CORPORATION also imports these cardiovascular products. Each links to the detailed product page.
About JAMP PHARMA CORPORATION
JAMP PHARMA CORPORATION imports 14 products worth $13.3M. Beyond Simvastatin, top products include Dapagliflozin, Apixaban, Acyclovir, Valacyclovir, Bisoprolol. View the complete JAMP PHARMA CORPORATION profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Simvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Simvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: JAMP PHARMA CORPORATION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as JAMP PHARMA CORPORATION's capped import value divided by total capped export value for Simvastatin across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching JAMP PHARMA CORPORATION importing Simvastatin, covering 39 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 84+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Simvastatin Import Data for JAMP PHARMA CORPORATION
Access order-level details, pricing data, supplier connections, and competitive analysis for JAMP PHARMA CORPORATION's Simvastatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JAMP PHARMA CORPORATION
Full Company Profile →
14 products · $13.3M total trade · 9 categories
JAMP PHARMA CORPORATION × Simvastatin
Verified from customs records
Company Overview
Top Products by JAMP PHARMA CORPORATION
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for JAMP PHARMA CORPORATION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Simvastatin. For current order-level data, contact TransData Nexus.